Evaluation of the Coris Legionella V-Test. In comparison with the Trinity Biotech EIA Legionella Urinary Antigen test
|
|
- Adele Parks
- 6 years ago
- Views:
Transcription
1 Evaluation of the Coris Legionella V-Test In comparison with the Trinity Biotech EIA Legionella Urinary Antigen test 06/September/2010 Coris BioConcept
2 Report of Clinical Performance Study of Legionella V-Test Coris BioConcept test in comparison with EIA Legionella Urinary Antigen test Trinity Biotech Truthful and Accurate Statement I, Jose Domínguez certify that, in my capacity as Senior Researcher, I believe to the best of my knowledge, that all data and information submitted in the above referenced Report of Clinical Performance Study are truthful and accurate and that no material fact has been omitted. These data belong to Coris BioConcept, therefore they can be used for any commercial purpose. Signature: Date: 06/ September/ 2010
3 Report of Clinical Performance Study of Legionella V-Test Coris BioConcept test in comparison with EIA Legionella Urinary Antigen test Trinity Biotech Place where test was performed: Servei de Microbiologia. Hospital Universitari Germans Trias I Pujol. Carretera del Canyet s/n Badalona. Barcelona. Spain Lead Investigator, Responsible Person of the investigation: Jose Domínguez Collaborator Investigator: Silvia Blanco Period of Testing: Two months after receiving the kits. Product evaluated: Legionella V-Test Coris BioConcept test Batch Number of kit: 2149H1006 Batch Number of sticks: 1W15G1013D Batch Number of extraction: - Comparator(s) Method(s): EIA Legionella Urinary Antigen test Trinity Biotech Batch Number of kit: - Brief description of that reference method used: The Bartels EIA assay (Bartels EIA Legionella Urinary Antigen. Bartels Inc., A Trinity Biotech Company, Wicklow, Ireland) is a direct sandwich test that uses polyclonal rabbit antibodies which react with L. pneumophila serogroup 1 antigen as the capture and detection antibody. Results were read using a microplate reader, although a visual interpretation was possible. Samples were considered positive when ratios were higher than 4 (the absorbance value was 4 times the absorbance value of the negative control). The test was performed following the manufacturer s instructions. Study Objective: The aim of this retrospective study was to evaluate the sensitivity and specificity of Legionella V-Test Coris BioConcept test in the diagnosis of Legionella pneumonia using non concentrated urine (), comparing the results to EIA Legionella Urinary Antigen test Trinity Biotech using concentrated urine (CU). Sample type tested and collection method: The test was performed using. The collected samples were stored at -80ºC.
4 Study Population and samples collected (number of samplings to test): Group 1.- Urine samples from 57 patients with pneumonia due to L. pneumophila will be studied. Legionnaires disease was diagnosed by isolation of L. pneumophila, by seroconversion, and/or by detection of soluble antigen in concentrated urine samples. Group 2.- Urine samples from 43 patients with confirmed pneumonia of other etiologies and patients with no clinical or radiological signs of pneumonia: healthy people, patients with bacteremia from a nonrespiratory focus, and patients with urinary tract infections. Methods employed: - EIA Legionella Urinary Antigen test Trinity Biotech - Legionella V-Test Coris BioConcept test - Amicon Ultra-4. Millipore Corporation. Bedford, MA Recommendations of the both manufacturers have been followed. Trials findings summary: Clinical Status POS NEG total Coris Test POS Non Concentrated Urine NEG total Sensitivity: 80.7% (TP/ (TP+FN)) Specificity: 100% (TN/ (TN+FP)) Reliability: 89% (TN+TP)/Total) Positive Predictive Value: Not applicable % (TP/(TP+FP)) Negative Predictive Value: Not applicable % (TN/ (TN+ FN)) The 11 urine samples with discordant result between CU EIA Bartels and ICT Coris results were retested by ICT Coris using CU. The antigen present in the 11 samples was concentrated 25 times by selective ultrafiltration. After concentration the ICT Coris was positive in 9 of the 11 samples (81.8%). Therefore, we could consider that the overall ICT Coris sensitivity was 96.5% (46+9/57). Interestingly, the 2 negative CU ICT Coris samples were also negative by the ICT Binax (Table 3). On the other hand, from the 11 urine samples with discordant result in 10 cases urine was available to test by the EIA Bartels using. The EIA Bartels was positive in 7 cases and negative in 3, being in the 3 cases the ICT Binax in and CU also negative (Table 3). A summary of the Study results are presented in the following figure.
5 Positive EIA Bartels CU n= 57 Positive ICT CORIS n= 46 Negative ICT CORIS n= 11 Positive ICT CORIS CU n= 9 Negative ICT CORIS CU n= 2 Negative ICT Binax n= 2 Positive EIA Bartels n= 7 Negative EIA Bartels n= 3 Urine sample not available n= 1 Negative ICT Binax & CU n= 3
6 Conclusion: 1. ICT Coris is a technique simple to perform, with good sensitivity and specificity, and the results are obtained in 15 minutes or less. 2. It s a good screening test to detect L. pneumophila antigen from urine samples. 3. Our results show that ICT Coris is comparable in sensitivity and specificity with the EIA Bartels. However, ITC Coris sensitivity is slightly lower than EIA Bartels in both non concentrated urine and concentrated urine samples. 4. The ICT Coris sensitivity increases using concentrated urine samples by selective ultrafiltration. 5. The technique is especially useful for small hospital laboratories without appropriate equipment and/or a small number of samples to perform the EIA Bartels test.
7 Table 1. Results for Each Specimen from patients Group 1 The status of samples is defined by the reference method used and should be notified as: N: Negative, P: Positive, TN: True Negative, TP: True Positive, FN: False Negative, FP: False Positive SN Sample Number Comparative technique Coris Test Results Positive Positive TP Positive Low Positive TP Positive Low Positive TP Positive Low Positive TP Positive Low Positive TP Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP A6 Positive Positive TP A5 Positive Positive TP A2 Positive Positive TP Positive Positive TP
8 SN Sample Number Comparative technique Coris Test Results Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP
9 Table 2. Results for Each Specimen from patients Group 2 SN Sample Number Comparative technique Coris Test Results 58 8 Negative Negative TN Negative Negative TN Negative Negative TN 61 9 Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN A3 Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN
10 Table 2. Discordant Results for Each Specimen from patients Group 1 SN Sample Number Comparative technique Coris Test Results Coris Test CU EIA Bartels Positive Negative FN Positive Positive Positive Negative FN Positive Positive Positive Negative FN Low Positive Positive Positive Negative FN Low Positive Positive - Additional results: ICT Binax & CU Positive Negative FN Negative Negative Negative Positive Negative FN Negative Negative Negative Positive Negative FN Positive Positive Positive Negative FN Positive Negative Negative () Positive Negative FN Positive Positive Negative () Positive Negative FN Low Positive N.A. Negative () Positive Negative FN Positive Positive -
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p. 2718 2722 Vol. 36, No. 9 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Comparison of the Binax Legionella
More informationImpact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults
Respiratory Medicine (2006) 100, 884 891 Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults Felipe Andreo a,, José Domínguez b, Juan Ruiz a, Silvia
More informationUtility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients
Respiratory Medicine (2010) 104, 397e403 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Utility of pneumococcal urinary antigen detection in diagnosing exacerbations
More informationReceived 3 August 2005/Returned for modification 13 September 2005/Accepted 13 January 2006
CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2006, p. 361 364 Vol. 13, No. 3 1556-6811/06/$08.00 0 doi:10.1128/cvi.13.3.361 364.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Evaluation
More informationEvaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella
JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationCommunity acquired pneumonia due to Legionella pneumophila in a tertiary care hospital
101 Research article Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital Abstract BN Dissanayake 1,, DE Jayawardena 2, CG Senevirathna 1, TM Gamage 1 Sri Lankan Journal
More informationSporadic and epidemic community legionellosis: two faces of the same illness
Eur Respir J 2007; 29: 138 142 DOI: 10.1183/09031936.00077206 CopyrightßERS Journals Ltd 2007 Sporadic and epidemic community legionellosis: two faces of the same illness N. Sopena*, L. Force #, M.L. Pedro-Botet*,
More informationAnnual Epidemiological Report
July 2018 Annual Epidemiological Report 1 Legionellosis in Ireland, 2017 Key Facts There were 25 cases of Legionnaires disease notified in Ireland in 2017 The rate per million population increased from
More informationSupplementary Online Content
Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory
More informationIMMUVIEW S. PNEUMONIAE AND L. PNEUMOPHILA URINARY ANTIGEN TEST. SSI Diagnostica ENGLISH
IMMUVIEW S. PNEUMONIAE AND L. PNEUMOPHILA URINARY ANTIGEN TEST Combined lateral flow test for qualitative detection of S. pneumoniae and L. pneumophila in urine and cerebrospinal fluid. ENGLISH SSI Diagnostica
More informationTrends in Human Immunodeficiency Virus Infection among Drug Users in a Detoxification Unit
SUPPLEMENT ARTICLE Trends in Human Immunodeficiency Virus Infection among Drug Users in a Detoxification Unit Roberto Muga, Arantza Sanvisens, José Manuel Egea, Jordi Tor, and Celestino Rey-Joly Department
More informationProbability Revision. MED INF 406 Assignment 5. Golkonda, Jyothi 11/4/2012
Probability Revision MED INF 406 Assignment 5 Golkonda, Jyothi 11/4/2012 Problem Statement Assume that the incidence for Lyme disease in the state of Connecticut is 78 cases per 100,000. A diagnostic test
More informationBiochemical investigations in clinical medicine
Biochemical investigations in clinical medicine Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Introduction What it is? Clinical
More informationCurrent and Emerging Legionella Diagnostics
Current and Emerging Legionella Diagnostics Nicole Wolter Centre for Respiratory Diseases and Meningitis (CRDM) National Institute for Communicable Diseases nicolew@nicd.ac.za 7 th FIDSSA Conference, Cape
More informationRapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Eur Respir J 2003; 21: 209 214 DOI: 10.1183/09031936.03.00058802 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Rapid urinary antigen test
More informationInternational Journal of Basic, Applied and Innovative Research
International Journal of Basic, Applied and Innovative Research ISSN: 2315-5388 RESEARCH PAPER IJBAIR, 2017, 6(3): 72-80 www.arpjournals.com; www.antrescentpub.com DETECTION OF LEGIONELLA ANTIGEN IN URINE
More informationLEGIONELLA PNEUMOPHILA IFA SLIDE
1 LEGIONELLA PNEUMOPHILA IFA SLIDE SLEPN: Slides kit for the diagnosis of Legionella pneumophila antibodies in human serum by indirect immunofluorescent assay (IFA). INTRODUCTION: More than 30 species
More informationIMMUVIEW. S. pneumoniae and L. pneumophila Urinary Antigen Test ENGLISH
IMMUVIEW S. pneumoniae and L. pneumophila Urinary Antigen Test ENGLISH Combined lateral flow test for qualitative detection of S. pneumoniae and L. pneumophila antigens in urine and S. pneumoniae in cerebrospinal
More informationIMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST. SSI Diagnostica
IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST SSI Diagnostica 2 IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST For in vitro diagnostic use Intended use The ImmuView and
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HCV 4.0 Number: PQDx Abstract
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: Bioelisa HCV 4.0 Number: PQDx 0165-060-00 Abstract Bioelisa HCV 4.0 with product codes 3000-1115 and 3000-1116, manufactured by Biokit
More informationSensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands
Journal of Medical Microbiology (2006), 55, 561 566 DOI 10.1099/jmm.0.46369-0 Sensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands Ed P. F. Yzerman,
More informationIMMUVIEW S. pneumoniae and L. pneumophila UrInary antigen test
IMMUVIEW S. pneumoniae and L. pneumophila UrInary antigen test EngLISh SSI Diagnostica Para otras lenguas Para outras linguas Für andere Sprachen Pour d autres langues Per le altre lingue For andre språk
More informationPCR Is Not Always the Answer
PCR Is Not Always the Answer Nicholas M. Moore, PhD(c), MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted
More informationCitation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.
University of Groningen Progress in diagnostics and prevention of Legionnaires' disease IJzerman, Eddy Peter Frans IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationLegionellosis. Legionnaires Disease Pontiac fever Rare non pneumonic infections 10/04/2015. Nonmotile replicative phase inside amoebae
Legionellosis Legionnaires Disease Pontiac fever Rare non pneumonic infections Planktonic flagellated virulent transmissive Nonmotile replicative phase inside amoebae 1 Biofilm in plumbing system 2 Clin
More informationHBsAg CONFIRMATORY TEST
HBsAg CONFIRMATORY TEST For the confirmation of positive samples with UMELISA HBsAg PLUS CLINICAL INTEREST After the discovery of Hepatitis B surface Antigen (HBsAg)(1), increasingly sensitive and specific
More informationIMMUVIEW S. PNEUMONIAE ANTIGEN TEST. Lateral flow test for qualitative detection of S. pneumoniae in urine and cerebrospinal fluid.
IMMUVIEW S. PNEUMONIAE ANTIGEN TEST Lateral flow test for qualitative detection of S. pneumoniae in urine and cerebrospinal fluid. 2 IMMUVIEW S. PNEUMONIAE ANTIGEN TEST For in vitro diagnostic use Application
More informationCitation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.
University of Groningen Progress in diagnostics and prevention of Legionnaires' disease IJzerman, Eddy Peter Frans IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationWHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract
WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Uni-Gold HIV Number: PQDx 0149-052-00 Abstract Uni-Gold HIV with product codes 1206502, 1206502N, 1206502E, 1206502N-100 manufactured
More informationCitation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.
University of Groningen Progress in diagnostics and prevention of Legionnaires' disease IJzerman, Eddy Peter Frans IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationTable Of Content. European Prevention Initiative for Dermatological Malignancies... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content European Prevention Initiative for Dermatological Malignancies... 2 Summary... 3 Coordinator, Leader contact and partners... 4 Sir Paul Boffa Hospital - SPBH... 4 Aristotle University
More informationNext Generation Rapid Diagnostics
Next Generation Rapid Diagnostics INTERNATIONAL PRODUCT CATALOG Quidel is a leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well-being of people around the globe
More informationWHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract
WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Uni-Gold HIV Number: PQDx 0149-052-00 Abstract Uni-Gold HIV with product codes 1206502, 1206502N, 1206502E, 1206502N-100 manufactured
More informationEvaluating reagents for serological diagnosis of Leptospirosis EPINET 1 Workshop (Guam, December 2001)
Evaluating reagents for serological diagnosis of Leptospirosis EPINET 1 Workshop (Guam, December 2001) Alain Berlioz-Arthaud, New Caledonia Pasteur Institute, B.P. 61, 98845 Noumea, NC aberlioz@pasteur.nc
More informationComparative evaluation of Immunochromatographic Assay for screening Hepatitis C among blood donors in a rural teaching hospital, Sangareddy
Original Research Article Comparative evaluation of Immunochromatographic Assay for screening Hepatitis C among blood donors in a rural teaching hospital, Sangareddy Nagababu Pyadala 1*, Prudhvi Chand
More informationChapter 10. Screening for Disease
Chapter 10 Screening for Disease 1 Terminology Reliability agreement of ratings/diagnoses, reproducibility Inter-rater reliability agreement between two independent raters Intra-rater reliability agreement
More informationInfluence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011
Influence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011 Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department
More informationA multicenter evaluation of the Biotest legionella
ORIGINAL ARTICLE A multicenter evaluation of the Biotest legionella urinary antigen EIA Timothy Harrison', Ssren Uldum', Stella Alexiou-Daniel3, Jette Bangsbo~g~, Sverker Be~nander~, Vladimir Drarar 6,
More informationClinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy
MAJOR ARTICLE Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy Analía Mykietiuk, 1 Jordi Carratalà, 1 Núria Fernández-Sabé,
More informationSubmitted: February 15, 2013 Posted: March 16, 2013
1 Submitted: February 15, 2013 Posted: March 16, 2013 TITLE: The results of the validation process of a Modified SGA (Subjective Global Assessment) Nutrition Assessment and Risk Level Tool designed by
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Department of Microbiology Princess Alexandra Hospital Hamstel Road Harlow CM20 1QX Contact: D Orriss Tel: +44 01279 827138 E-Mail: Debbie.Orriss@pah.nhs.uk
More informationImpact of pre-hospital antibiotic use on community-acquired pneumonia
ORIGINAL ARTICLE INFECTIOUS DISEASE Impact of antibiotic use on community-acquired pneumonia A. F. Simonetti 1, D. Viasus 1,2, C. Garcia-Vidal 1,2, S. Grillo 1, L. Molero 1, J. Dorca 3,4 and J. Carratala
More informationUnderstanding diagnostic tests. P.J. Devereaux, MD, PhD McMaster University
Understanding diagnostic tests P.J. Devereaux, MD, PhD McMaster University Goals Understand sensitivity and specificity inform why they are in general problematic Discuss likelihood ratios Inform pretest
More informationMAESTRO TRIAL FINAL RESULTS. Gisela L.G. Menezes, MD, PhD
MAESTRO TRIAL FINAL RESULTS Gisela L.G. Menezes, MD, PhD MAESTRO Angiogenesis Metastasis How does OA work? Malignant Benign How does OA work? D O How does OA work? Optoacoustic Imaging Fibroadenoma IDC
More information4.6. How to test - testing strategy HCV. Decision-making tables PICO 4
4.6. How to test - testing strategy HCV Decision-making tables PICO 4 Testing strategy to ascertain exposure to HCV: Among persons identified for hepatitis C testing, what is the best testing strategy
More informationWHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx
WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx 0183-060-00 Abstract Bioelisa HIV 1+2 Ag/Ab with product codes 3000-1172 and 300-1173,
More informationSensitivity, Specificity, and Relatives
Sensitivity, Specificity, and Relatives Brani Vidakovic ISyE 6421/ BMED 6700 Vidakovic, B. Se Sp and Relatives January 17, 2017 1 / 26 Overview Today: Vidakovic, B. Se Sp and Relatives January 17, 2017
More informationMouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit
Mouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit Catalogue No.: EM0002 Size: 96T Reactivity: Mouse Application: This immunoassay kit allows for the qualitative determination of HBsAg in Mouse serum
More informationData that can be classified as belonging to a distinct number of categories >>result in categorical responses. And this includes:
This sheets starts from slide #83 to the end ofslide #4. If u read this sheet you don`t have to return back to the slides at all, they are included here. Categorical Data (Qualitative data): Data that
More informationEpidemiology of Legionnaires Disease in Europe Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016
Epidemiology of Legionnaires Disease in Europe 2015 Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016 ELDSNet annual data set Methods ECDC coordination Collection of disaggregate
More informationIdentification of a cytokine expression pattern specific for the first month of HIV infection
Abstract no. TUPEA023 Identification of a cytokine expression pattern specific for the first month of HIV infection Pastor L (1)(2)(3), Parker E (4), Carrillo J (1)(2), Urrea V (1), Fuente-Soro L (2)(5),
More informationDAILY PROGRAMME HIGHLIGHTS
DAILY PROGRAMME HIGHLIGHTS Please visit the programme page on the conference website for a full list of conference sessions and satellite meetings taking place at the CCIB or offsite, as well as a daily
More informationSAMPLE. Collecting a faeces specimen
7. Perform steps 10 16 of the common steps (see pp. 39 43). Evidence base: PHE (2014a) To ensure that: the patient is safe and comfortable. the specimen has been correctly collected and documented in the
More informationInstitut Pasteur de Nouvelle Calédonie 12 / 12 / 02
Evaluation of reagents for the serological diagnosis of Dengue EPINET II Workshop (Noumea, March, 2002) Alain BERLIOZ-ARTHAUD, New Caledonia Pasteur Institute, B.P. 61, 98845 Noumea, NC aberlioz@pasteur.nc
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Derriford Hospital Derriford Road Plymouth PL6 8DH Contact: John Hooper Tel: +44 (0) 1752 792369 E-Mail: johnhooper@nhs.net Website: www.plymouthhospitals.nhs.uk/pathologywelcome
More informationThe NEPHROCHECK Test System Training Program. The NEPHROCHECK Training Program US: Astute Medical, Inc PN Rev D 2014/09/16
The NEPHROCHECK Test System Training Program The NEPHROCHECK Training Program US: Astute Medical, Inc. 2014 PN 700001 Rev D 2014/09/16 Learning Objectives At the conclusion of this training, participants
More informationTHIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 25, 2018 0800 EDT NH-HAN 20180825 Cluster of Legionella pneumophila Pneumonia (Legionnaire
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationDraft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc)
Date: 6 January 2012 Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) WHO Collaborating Centre for HIV/AIDS Diagnostic and Laboratory Support Department of Clinical Sciences
More informationWithin 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma
Test Name *Minimum Collection Tubes Sample Stability ABO/Rh Blood Typing 50 µl cells EDTA whole blood (lavender-top) Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma
More informationWHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx
WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Murex HIV Ag/Ab Combination Number: PQDx 0144-043-00 Abstract Murex HIV Ag/Ab Combination with product codes 7G79-09 (GE41,
More informationHIV-1 ICx/CRx Kit Reagents for Immune Dissociation and Reactivity Confirmation
INTENDED USE The RETRO-TEK HIV-1 IC x/cr x Kit is supplied for research purposes only. It is not intended for use in the diagnosis or prognosis of disease or for screening and may not be used as a confirmatory
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Alere Determine HIV-1/2 Number: PQDx Abstract
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: Alere Determine HIV-1/2 Number: PQDx 0033-013-00 Abstract The Alere Determine HIV-1/2 with product codes 1 7D2342, 7D2343 and 7D2243
More informationOptimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations Immunotherapy in the clinic Melanoma
Optimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations Immunotherapy in the clinic Melanoma Dr. J.L.Manzano S. Oncología Médica H. Germans Trias i Pujol, ICO-Badalona PRBB Auditorium,
More informationBiomedical Engineering for Global Health
Four Questions Biomedical Engineering for Global Health Lecture Eleven What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems?
More informationAnnals of the American Thoracic Society
Annals of the American Thoracic Society Sensitivity, specificity and positivity predictors of the pneumococcal urinary antigen test in community acquired pneumonia Journal: Annals of the American Thoracic
More informationAssessment of diabetic retinopathy risk with random forests
Assessment of diabetic retinopathy risk with random forests Silvia Sanromà, Antonio Moreno, Aida Valls, Pedro Romero2, Sofia de la Riva2 and Ramon Sagarra2* Departament d Enginyeria Informàtica i Matemàtiques
More informationIMTEC-ANA-LIA MAXX. Design Verification
Design Verification IMTEC-ANA-LIA MAXX CONTENTS 1 Intended Use... 2 2 Diagnostic Sensitivity and Specificity... 2 3 Interferences... 4 4 Imprecision... 6 4.1 Within-Run Imprecision... 6 4.2 Between-Run
More informationH5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set
H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set Catalog Number : SEK002 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized
More informationGuideline on the management of Legionella cases, incidents, outbreaks and clusters in the community Quick Reference Guide
2 2014 Edition Guideline on the management of Legionella cases, incidents, outbreaks and clusters in the community Quick Reference Guide Health Protection Network Scottish Guidance November 2014 Initial
More informationPCR Is Not Always the Answer
PCR Is Not Always the Answer Nicholas M. Moore, PhD, MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted research:
More informationMurex Chlamydia Verification Kit
1F83-01 E C06DK05GB Murex Chlamydia Verification Kit DK05 For the confirmatory testing of clinical samples reactive in Murex Chlamydia (1F82-01) Note Changes Highlighted 2005 Abbott / Printed in the UK
More informationBioengineering and World Health. Lecture Twelve
Bioengineering and World Health Lecture Twelve Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How
More informationL egionella pneumophila (LP) is, in most studies,
Comparative Study of the Clinical Presentation of Legionella Pneumonia and Other Community-Acquired Pneumonias* Nieves Sapena, MD; Miquel Sabria-Leal, MD, PhD; Maria Lluisa Pedro-Botet, MD, PhD; Eduardo
More informationHuman Legionella ELISA Kit
Human Legionella ELISA Kit Cat.No:DEIA1721 Lot. No. (See product label) PRODUCT INFOMATION Storage Pkg#Size Intended use Principle Of The Test Reagents And Materials Provided 1. Store the unopened kit
More informationEvidence-based guidelines for diagnosis of common bile duct stones Vanja Giljaca University Hospital Center Rijeka Department of Gastroenterology
Evidencebased guidelines for diagnosis of common bile duct stones Vanja Giljaca University Hospital Center Rijeka Department of Gastroenterology Trusted evidence. Informed decisions. Better health. Outline
More informationReQuest EB VCA IgM L
01-480 96-Test Set For in Vitro Diagnostic Use Only Intended Use: For the qualitative detection of human IgM antibodies to Epstein-Barr (EB) viral capsid antigen (VCA) in human serum by enzyme immunoassay,
More informationInfluenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set
Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay
More informationPreventing Legionella Transmission An Environmental Health View
Preventing Legionella Transmission An Environmental Health View April 25, 2013 Erin Reinsborough Environmental Health Specialist Mission Statement Together with the Halton community, the Health Department
More information100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010
Currently Approved CBER Device Premarket Applications (PMAs) As of Nov 10, 2014 Sorted by Applicant Name BP090080-0 BP060002-0 BP120037-0 BP090022-0 BP090032-0 BP040046-0 BP100064-0 BP140120-0 Abbott Laboratories
More informationD-FRUCTOSE and D-GLUCOSE
www.megazyme.com DFRUCTOSE and DGLUCOSE (Liquid Stable Format) ASSAY PROCEDURE KFRGLQR 02/17 (1100 AutoAnalyser Assays of each per Kit) or (1100 Microplate Assays of each per Kit) Megazyme 2017 INTRODUCTION:
More informationTSH (Human) CLIA Kit. Catalog Number KA assays Version: 01. Intended for research use only.
TSH (Human) CLIA Kit Catalog Number KA2795 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationValue of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline
Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline Presenter: Elisabetta Fenu, Health Economics Lead Co-author: Chris Kiff National Clinical Guideline
More informationEPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region. Namitha Reddy Regional Coordinator North/Central West Region
EPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region Namitha Reddy Regional Coordinator North/Central West Region 1 This report is for use by Public Health Officials only and not for public distribution.
More informationDiagnostic tests, Laboratory tests
Diagnostic tests, Laboratory tests I. Introduction II. III. IV. Informational values of a test Consequences of the prevalence rate Sequential use of 2 tests V. Selection of a threshold: the ROC curve VI.
More informationFigure 1: Design and outcomes of an independent blind study with gold/reference standard comparison. Adapted from DCEB (1981b)
Page 1 of 1 Diagnostic test investigated indicates the patient has the Diagnostic test investigated indicates the patient does not have the Gold/reference standard indicates the patient has the True positive
More informationCritical Appraisal. Einas Al-Eisa, MSc, PhD King Saud University
Critical Appraisal Einas Al-Eisa, MSc, PhD King Saud University Critical Appraisal = assessment of evidence by systematically reviewing its: Relevance Validity Applicability of its results to specific
More informationWith the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV 1+2 Ag/Ab from 10 to 12 months.
1 NEWS BK NEWS # 377 /MKT DATE : 18-01-2016 TITLE : SHELF-LIFE EXTENSION OF bioelisa HIV 1+2 Ag/Ab With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV
More informationHealth Studies 315: Handouts. Health Studies 315: Handouts
Health Studies 315: Handouts Health Studies 315: Handouts l Lecture Notes l Last YearÍs Exam l Article: Wagner, JM, McKinney, P, Carpenter, JL. Does this patient have appendicitis? JAMA 276(19):1589-1594
More information2006 HIV Diagnostics Survey
Public Health Laboratory Issues in Brief: 2006 HIV Diagnostics Survey Association of Public Health Laboratories November 2007 Background Nearly 20 years ago, the Association of Public Health Laboratories
More informationRELIABILITY OF OPERATORS DURING THE VISUAL INSPECTION OF PRODUCED PARENTERAL DRUGS
RELIABILITY OF OPERATORS DURING THE VISUAL INSPECTION OF PRODUCED PARENTERAL DRUGS F. Sadeghipour, A. Bugmann, V. Herrera, P. Bonnabry Geneva, 22 March 2006 11th Congress of the European Association of
More informationELEGANCE Chlamydia pneumoniae IgG ELISA KIT
INTENDED USE The ELEGANCE Chlamydia pneumoniae IgG ELISA has been designed for the in vitro diagnostic measurement of anti- Chlamydia pneumoniae IgG in the screening of human serum. PRINCIPLES OF THE ELEGANCE
More informationEvaluation of the LIAISON Treponema Assay, a Chemiluminescent Immunoassay ACCEPTED
CVI Accepts, published online ahead of print on 25 April 2007 Clin. Vaccine Immunol. doi:10.1128/cvi.00068-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationBIOE 301. Lecture Eleven
BIOE 301 Lecture Eleven Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How are health care technologies
More informationLegionnaire s disease is a febrile illness with pneumonia. The Radiologic Manifestations of Legionnaire s Disease*
The Radiologic Manifestations of Legionnaire s Disease* Michael J. Tan, MD; James S. Tan, MD, FCCP; Robert H. Hamor, MD; Thomas M. File, Jr., MD, FCCP; Robert F. Breiman, MD; and the Ohio Community-Based
More informationBIOE 301. The Burden of Cancer: U.S. Four Questions. Lecture Eleven. Three Case Studies. Outline. U.S. Cancer Incidence & Mortality 2009
Four Questions BIOE 31 Lecture Eleven What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How are health care technologies
More informationWHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Alere HIV/Syphilis Duo Number: PQDx
WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Alere HIV/Syphilis Duo Number: PQDx 0179-012-00 Abstract Alere HIV/Syphilis Duo with product codes 06FK30 and 06FK35, manufactured
More informationMAJOR ARTICLE. Atypical Pneumonia in Thailand CID 2007:45 (15 December) e147
MAJOR ARTICLE Epidemiology of Severe Pneumonia Caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-Year, Population- Based Surveillance for Severe Pneumonia in Thailand
More informationUrine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016
Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of
More informationChlamydia MIF IgG. Performance Characteristics. Product Code IF1250G Rev. J. Not for Distribution in the United States
Product Code IF1250G Rev. J Performance Characteristics Not for Distribution in the United States EXPECTED VALUES Community Acquired Pneumonia Population Two outside investigators assessed the Focus Chlamydia
More information